ON THE MENU
Stay tuned for upcoming event details.
PAST BIOTEXAS CAFE EVENTS
BioTexas Cafe - The Promise of Personalized Medicine: CAR T-Cell Therapy
Sponsored by Bristol Myers Squibb
October 15, 2020
BioTexas Cafe featuring special guest, Dr. Michele Sharr McMahon, Director, Global Drug Development at Bristol Myers Squibb.
Recording coming soon.
THBI President's Call with Special Guest, Elliott Francis
Tom Kowalski, THBI's President and CEO, speaks with Elliott M. Francis, Director of Diversity and Inclusion at Biotechnology Innovation Organization (BIO). Elliott shares insight on his leadership role to drive change through the development and implementation of strategic diversity and inclusion initiatives in the biotechnology and life sciences industry, and within BIO.
BioTexas Cafe - A Discussion on COVID-19 Vaccines and Therapeutics
Co-Hosted by Texas Association of Manufacturers
In partnership with Texas Association of Manufacturers (TAM), Tom Kowalski, President and CEO of THBI, Tony Bennett, President and CEO of TAM, and our member companies provide an update on COVID-19 vaccines and therapeutics and how companies produce and distribute these products.
The Latest on COVID-19, A Town Hall Discussion
Sponsored by Amgen
THBI President's Call with Special Guest Wayne Roberts
THBI President's Call with Special Guests Tony Mitchell and Scott Newkirk
THBI President's Call with Special Guest Emma Schwartz
COVID-19 and the Important Role of Manufacturing
COVID-19 and the Importance of Policy on Public Health
This presentation was focused on the importance of public policy in fighting public health crises. Dr. Rodney Rohde, Professor and Chair for the Clinical Laboratory Science (CLS) Program in the College of Health Professions at Texas State University and Tom Kowalski, CEO of THBI discuss best practices policy leaders can learn from COVID-19 and how to be better prepared for the next virus.
THBI COVID-19 Webinar with Texas Biomedical Research Institute
Hear the latest COVID-19 research and development efforts being conducted at the Texas Biomedical Research Institute campus in San Antonio. Dr. Larry Schlesinger, CEO and Dr. Joanne Turner, Vice President for Research will discuss the Institute’s unique role in the bioscience landscape and how its team of researchers are tackling the newest threat – COVID-19 – followed by a Q&A!